Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078

Journal of Medical Microbiology

Volumn 62, Issue , 2013, Pages 1486-1489

  Tagashira, Yasuaki ^a   Kato, Haru ^b   Senoh, Mitsutoshi ^b   Nakamura, Akira ^a  

^a ASAHI GENERAL HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CLOSTRIDIUM TOXIN; CLOSTRIDIUM TOXIN A; CLOSTRIDIUM TOXIN B; DOPAMINE; METRONIDAZOLE; NORADRENALIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASCENDING COLON; ASCITES; AUTOPSY; BACTERIUM DETECTION; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; COLON HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; EDEMA; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; FULMINANT COLITIS; HUMAN; INTENSIVE CARE; INTUBATION; JAPANESE; KIDNEY INJURY; LEUKOCYTE COUNT; MALE; PANCOLITIS; PRIORITY JOURNAL; SEPTIC SHOCK; SIGMOID;

ADP RIBOSE TRANSFERASES; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL PROTEINS; BASE SEQUENCE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS; FATAL OUTCOME; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RIBOTYPING;

EID: 84881606922     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.057968-0     Document Type: Article

References (15)

1. Bacci, S., Mølbak, K., Kjeldsen, M. K. & Olsen, K. E. (2011). Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis 17, 976-982.
2. Bauer, M. P., Notermans, D. W., van Benthem, B. H., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., van Dissel, J. T., Kuijper, E. J. & ECDIS Study Group (2011). Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377, 63-73.
3. Goldenberg, S. D. & French, G. L. (2011). Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 62, 355-362.
4. Goorhuis, A., Van der Kooi, T., Vaessen, N., Dekker, F. W., Van den Berg, R., Harmanus, C., van den Hof, S., Notermans, D. W. & Kuijper, E. J. (2007). Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 45, 695-703.
5. Goorhuis, A., Bakker, D., Corver, J., Debast, S. B., Harmanus, C., Notermans, D. W., Bergwerff, A. A., Dekker, F. W. & Kuijper, E. J. (2008). Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47, 1162-1170.
6. Iwashima, Y., Nakamura, A., Kato, H., Kato, H., Wakimoto, Y., Wakiyama, N., Kaji, C. & Ueda, R. (2010). A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients. J Infect Chemother 16, 329-333.
7. Kato, H., Ito, Y., van den Berg, R. J., Kuijper, E. J. & Arakawa, Y. (2007). First isolation of Clostridium difficile 027 in Japan. Euro Surveill 12, E070111.3.
8. Kato, H., Kato, H., Ito, Y., Akahane, T., Izumida, S., Yokoyama, T., Kaji, C. & Arakawa, Y. (2010). Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing. J Med Microbiol 59, 556-562.
9. Miller, M., Gravel, D., Mulvey, M., Taylor, G., Boyd, D., Simor, A., Gardam, M., McGeer, A., Hutchinson, J. & other authors (2010). Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 50, 194-201.
10. Morris, A. M., Jobe, B. A., Stoney, M., Sheppard, B. C., Deveney, C. W. & Deveney, K. E. (2002). Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg 137, 1096-1100.
11. Redelings, M. D., Sorvillo, F. & Mascola, L. (2007). Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 13, 1417-1419.
12. Sawabe, E., Kato, H., Osawa, K., Chida, T., Tojo, N., Arakawa, Y. & Okamura, N. (2007). Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 26, 695-703.
13. Spigaglia, P. & Mastrantonio, P. (2002). Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40, 3470-3475.
14. Stubbs, S. L., Brazier, J. S., O'Neill, G. L. & Duerden, B. I. (1999). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37, 461-463.
15. Walk, S. T., Micic, D., Jain, R., Lo, E. S., Trivedi, I., Liu, E. W., Almassalha, L. M., Ewing, S. A., Ring, C. & other authors (2012). Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 55, 1661-1668.